CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More

Written by Emily J. Thompson, Senior Investment Analyst

CYTH%

Source: NASDAQ.COM

Updated: Mar 15 2025

0mins

Source: NASDAQ.COM

Earnings Release: CYCLO THERAPEUTICS ($CYTH) is set to announce its quarterly earnings on March 17th, with analysts predicting revenue of $328,440 and a loss of -$0.17 per share.
Investor Activity: Recent data shows that 6 institutional investors have increased their holdings in CYCLO THERAPEUTICS, while 9 have reduced their positions in the last quarter.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

CYCLO THERAPEUTICS Earnings Preview: Recent $CYTH Insider Trading, Hedge Fund Activity, and More

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Faruqi & Faruqi Encourages Gauzy Investors to Discuss Claims

Faruqi & Faruqi Investigates Alexandria Real Estate Equities for Securities Fraud After 19% Stock Drop

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch